Patrick J. Nolan

Array ( [id] => 3953730 [patent_doc_number] => 05935801 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Monoclonal antibody that detects apoptotic antigen' [patent_app_type] => 1 [patent_app_number] => 8/623876 [patent_app_country] => US [patent_app_date] => 1996-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 6554 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935801.pdf [firstpage_image] =>[orig_patent_app_number] => 623876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4018954 [patent_doc_number] => 05882644 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Monoclonal antibodies specific for the platelet derived growth factor .beta. receptor and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/621751 [patent_app_country] => US [patent_app_date] => 1996-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 18377 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882644.pdf [firstpage_image] =>[orig_patent_app_number] => 621751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 988258 [patent_doc_number] => 06921813 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-07-26 [patent_title] => 'DNA Molecules' [patent_app_type] => utility [patent_app_number] => 08/624396 [patent_app_country] => US [patent_app_date] => 1996-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4574 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/921/06921813.pdf [firstpage_image] =>[orig_patent_app_number] => 08624396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177109 [patent_doc_number] => 06037175 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Method and media for enhancing cryopreservation of cells' [patent_app_type] => 1 [patent_app_number] => 8/615039 [patent_app_country] => US [patent_app_date] => 1996-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 4316 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037175.pdf [firstpage_image] =>[orig_patent_app_number] => 615039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936015 [patent_doc_number] => 05871901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Assay for inhibitors of DP-1 and other DP proteins' [patent_app_type] => 1 [patent_app_number] => 8/602846 [patent_app_country] => US [patent_app_date] => 1996-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 21 [patent_no_of_words] => 15249 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871901.pdf [firstpage_image] =>[orig_patent_app_number] => 602846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4050262 [patent_doc_number] => 05932447 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica' [patent_app_type] => 1 [patent_app_number] => 8/597731 [patent_app_country] => US [patent_app_date] => 1996-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 9797 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932447.pdf [firstpage_image] =>[orig_patent_app_number] => 597731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784708 [patent_doc_number] => 05821334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Insulin-dependent diabetes mellitus-specific chimeric polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/592696 [patent_app_country] => US [patent_app_date] => 1996-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8375 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821334.pdf [firstpage_image] =>[orig_patent_app_number] => 592696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3981666 [patent_doc_number] => 05948893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Murine hybridoma and antibody binding to CD28 receptor secreted by the hybridoma and method of using the antibody' [patent_app_type] => 1 [patent_app_number] => 8/587609 [patent_app_country] => US [patent_app_date] => 1996-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 31 [patent_no_of_words] => 8731 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948893.pdf [firstpage_image] =>[orig_patent_app_number] => 587609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995287 [patent_doc_number] => 05922570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Cytoplasmic Modulators of Integrin Binding/Signalling' [patent_app_type] => 1 [patent_app_number] => 8/583562 [patent_app_country] => US [patent_app_date] => 1996-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23658 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922570.pdf [firstpage_image] =>[orig_patent_app_number] => 583562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805818 [patent_doc_number] => 05830877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory' [patent_app_type] => 1 [patent_app_number] => 8/464878 [patent_app_country] => US [patent_app_date] => 1996-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 39 [patent_no_of_words] => 19720 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830877.pdf [firstpage_image] =>[orig_patent_app_number] => 464878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942576 [patent_doc_number] => 05976867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Use of serospecific biocarrier compositions for enhanced biodegradation and bioremediation of groundwater' [patent_app_type] => 1 [patent_app_number] => 8/583151 [patent_app_country] => US [patent_app_date] => 1995-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4429 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976867.pdf [firstpage_image] =>[orig_patent_app_number] => 583151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723218 [patent_doc_number] => 05670157 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Method for reducing and controlling immunoglobulin concentrations' [patent_app_type] => 1 [patent_app_number] => 8/570098 [patent_app_country] => US [patent_app_date] => 1995-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3987 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670157.pdf [firstpage_image] =>[orig_patent_app_number] => 570098 [rel_patent_id] =>[rel_patent_doc_number] =>)